Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers
Kirkpatrick, B.D., McKenzie, Robin, O’Neill, J. Patrick, Larsson, Catherine J., Bourgeois, A. Louis, Shimko, Janet, Bentley, Matthew, Makin, Jill, Chatfield, Steve, Hindle, Zoë, Fidler, Christine, Robinson, Brad E., Ventrone, Cassandra H., Bansal, Nivedita, Carpenter, Colleen M., Kutzko, Deborah, Hamlet, Sandra, LaPointe, Casey, Taylor, David N.
Published in Vaccine (12.01.2006)
Published in Vaccine (12.01.2006)
Get full text
Journal Article
Evaluation ofSalmonella entericaserovar Typhi (Ty2aroC-ssaV-) M01ZH09, with a defined mutation in theSalmonellapathogenicity island 2, as a live, oral typhoid vaccine in human volunteers
Kirkpatrick, BD, McKenzie, Robin, O'Neill, J Patrick, Larsson, Catherine J, Bourgeois, A Louis, Shimko, Janet, Bentley, Matthew, Makin, Jill, Chatfield, Steve, Hindle, Zoë, Fidler, Christine, Robinson, Brad E, Ventrone, Cassandra H, Bansal, Nivedita, Carpenter, Colleen M, Kutzko, Deborah, Hamlet, Sandra, LaPointe, Casey, Taylor, David N
Published in Vaccine (12.01.2006)
Published in Vaccine (12.01.2006)
Get full text
Journal Article